On November 12, 2020 Vaccibody AS, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies,reported that its CEO, Michael Engsig, and President and CSO, Agnete Fredriksen, Ph.D., will give a presentation of Vaccibody at the Jefferies 2020 Virtual London Healthcare Conference at 12.10 pm CET / 06.10 am EDT on November 19, 2020 (Press release, Vaccibody, NOV 12, 2020, View Source [SID1234570754]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A webcast, which will include a Q&A session, of the event and the presentation material will be available on Vaccibody’s website at View Source